eli lilly retatrutide clinical trials weight loss New Phase 3 data just dropped 👀 Lilly's trial reported average approaching 30%, with some patients White House denies Trump is

Rare but more serious side effects, such as gallbladder issues or pancreatitis, may occur and require immediate medical attention

TRANSCEND-T2D-1 detailed results are scheduled for the American Diabetes Association Scientific Sessions in June 2026

Duration changes the result as much as laboratory potency does

Until properly designed, peer-reviewed human clinical trials are completedand an FDA-regulated production pathway existsclinicians should remain cautious and avoid its clinical use in patients

(PubMed) Jones W, Li X, Qu ZC, Perriott L, Whitesell RR, May JM

Dozens of providers now compete for patients, and telling them apart can be difficult